NCT02199886View on ClinicalTrials.gov

Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection

PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

December 31, 2001

Conditions
Lung Neoplasms
Interventions
DRUG

BIBH 1

labeled with eight to ten millicurie of 131I

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY